DEVON CHARLTON: Open Payments
NPI 1215203443 · NEW CASTLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$53,190 in 105 payments from 10 companies in 2025. Trend: 2023 $29,791 · 2024 $36,820 · 2025 $53,190
Speaker / faculty: $40,838Travel & lodging: $5,524Consulting: $3,640Food & beverage: $3,188
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $25,172 |
| Janssen Biotech, Inc. | 32 | $25,125 |
| UCB, Inc. | 8 | $2,517 |
| Amgen Inc. | 3 | $158 |
| AstraZeneca Pharmaceuticals LP | 5 | $83 |
| GlaxoSmithKline, LLC. | 3 | $66 |
| Aurinia Pharma U.S., Inc. | 1 | $26 |
| Janssen Scientific Affairs, LLC | 2 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| Swing Therapeutics, Inc. | 1 | $10 |
Products named: TREMFYA, RINVOQ, SKYRIZI, Bimzelx, EVENITY, SAPHNELO, BENLYSTA, LUPKYNIS.
Industry payments across PA — which companies pay providers there.
